Niva Bupa Health Insurance Company Limited, formerly known as Max Bupa Health Insurance Company Limited, has announced a personalized group plan for comprehensive cancer treatment coverage at an affordable annual premium. Leading Health launched this plan at a cost of Rs 1,499 plus tax. This product was developed by Niva Bupa in consultation with the Indian Cancer Society (ICS), the company said in a press release.
“Although state-of-the-art cancer treatment is available in India, it is expensive and many families who are not covered by any government scheme, nor have any private health insurance coverage, have to bear the medical expenses of their own pockets, which leads to financial stress. . Existing private health insurance plans covering cancer are mostly very expensive for an ordinary person,” Niva Bupa said in the press release on Thursday.
The Indian Cancer Society has recognized this as a critical need and has partnered with Niva Bupa to develop a cancer control plan to fill this gap.
This group insurance plan is designed with the needs of low and middle income families in mind and covers not only hospitalization but also daycare costs like radiotherapy, chemotherapy, etc. at a nominal premium. This family floating scheme offers INR 5 lakh coverage for up to two adults and three children (for families who do not have cancer).
The cancer control plan will be particularly beneficial for the lower socioeconomic strata and would enable customers to enjoy cashless treatment at more than 80,000 network hospitals grouped with Niva Bupa, the insurer said.
“For people above these limits and on average incomes, there are no insurance products that are affordable and lessen the financial burden of holistic cancer treatment. The experience of the Indian Cancer Society Cancer Cure Fund shows that the cover of Rs 5 lakh will cover the cost of treating the most common cancers. We are happy that Niva Bupa has responded to our challenge and launched an affordable group insurance plan,” said Usha Thorat, Trustee of Indian Cancer Society.
Krishnan Ramachandran, MD and CEO of Niva Bupa said, “This product will especially enable people from low income groups to eliminate the possible risk of poverty resulting from expensive cancer treatment and provide them with full peace of mind.”
“The association with ICS aligns well with Niva Bupa’s vision to democratize health insurance and provide access to health services for millions of people in the country,” he added.
The product includes additional benefits, such as coverage for organ transplantation as well as other modern treatments including oral chemotherapy, immunotherapy, robotic surgeries, proton therapy, personalized and targeted therapy, hormone therapy or endocrine manipulation, pre- and post-hospitalization coverage for ages 30+. 90 days respectively.
Read all the latest Ukraine-Russia war news, breaking news and live updates here.